title: Obeticholic acid and resveratrol in nonalcoholic fatty liver disease: all that is gold does not glitter, not all those who wander are lost.
authors.affiliation: Gradenigo Hospital, Torino, Italy.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Musso
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002635:Chenodeoxycholic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D065626:Non-alcoholic Fatty Liver Disease / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists; D000077185:Resveratrol; D013267:Stilbenes / Q000627:therapeutic use*; D000099150:Receptor, Farnesoid X-Activated
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D002635:Chenodeoxycholic Acid; D018160:Receptors, Cytoplasmic and Nuclear; D000077185:Resveratrol; D013267:Stilbenes; D000099150:Receptor, Farnesoid X-Activated; C464660:obeticholic acid